Cargando…
The efficacy of anakinra compared to standard care of treatment for COVID-19: a meta-analysis
BACKGROUND/AIM: As SARS-CoV-2 continues to spread worldwide, this study brings to light the link that anakinra, a recombinant IL-1 receptor antagonist, has in averting grave clinical outcomes. The objectives of this meta-analysis are to investigate the effects of anakinra in interventional groups co...
Autores principales: | MALIK, Hamna, BINT ABDUL JABBAR, Hira, LATIF, Farah, SARFRAZ, Azza, SARFRAZ, Zouina, SARFRAZ, Muzna |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Scientific and Technological Research Council of Turkey (TUBITAK)
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10390186/ https://www.ncbi.nlm.nih.gov/pubmed/36326309 http://dx.doi.org/10.55730/1300-0144.5345 |
Ejemplares similares
-
Venous Thromboembolism, Corticosteroids and COVID-19: A Systematic Review and Meta-Analysis
por: Sarfraz, Azza, et al.
Publicado: (2021) -
Anakinra treatment efficacy in reduction of inflammatory biomarkers in COVID‐19 patients: A meta‐analysis
por: Naveed, Zunaira, et al.
Publicado: (2022) -
Tocilizumab and COVID-19: a meta-analysis of 2120 patients with severe disease and implications for clinical trial methodologies
por: SARFRAZ, Azza, et al.
Publicado: (2021) -
Gender-based violence in Pakistan and public health measures: a call to action
por: Sarfraz, Azza, et al.
Publicado: (2022) -
Ripple Collision of Three Epidemics: Vaping, Opioid Use, and COVID-19
por: Sarfraz, Zouina, et al.
Publicado: (2021)